Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-19

Clinical Trial Update: Efficacy, Safety and Tolerability of Telbivudine in HBeAg Positive Chronic Hepatitis B Pregnant Women With Elevated Alanine Aminotransferase Levels [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the efficacy, safety, and tolerability of telbivudine in HBeAg-positive pregnant women with chronic hepatitis B and elevated ALT; the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telbivudine (telbivudine)

Snippet

Sponsor: Southeast University, China | Conditions: Chronic Hepatitis B, Pregnancy Complications | Phase 4 | Status: COMPLETED